MXPA04000627A - COMPOSICIONES FARMACeUTICAS Y USO DE LAS MISMAS. - Google Patents

COMPOSICIONES FARMACeUTICAS Y USO DE LAS MISMAS.

Info

Publication number
MXPA04000627A
MXPA04000627A MXPA04000627A MXPA04000627A MXPA04000627A MX PA04000627 A MXPA04000627 A MX PA04000627A MX PA04000627 A MXPA04000627 A MX PA04000627A MX PA04000627 A MXPA04000627 A MX PA04000627A MX PA04000627 A MXPA04000627 A MX PA04000627A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
compositions containing
terbinafin
containing terbinafin
minitablets
Prior art date
Application number
MXPA04000627A
Other languages
English (en)
Spanish (es)
Inventor
Alles Rainer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27256227&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA04000627(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0117760A external-priority patent/GB0117760D0/en
Priority claimed from GB0128993A external-priority patent/GB0128993D0/en
Priority claimed from GB0212209A external-priority patent/GB0212209D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MXPA04000627A publication Critical patent/MXPA04000627A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MXPA04000627A 2001-07-20 2002-07-19 COMPOSICIONES FARMACeUTICAS Y USO DE LAS MISMAS. MXPA04000627A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0117760A GB0117760D0 (en) 2001-07-20 2001-07-20 Organic compounds
GB0128993A GB0128993D0 (en) 2001-12-04 2001-12-04 Organic compounds
GB0212209A GB0212209D0 (en) 2002-05-27 2002-05-27 Organic compounds
PCT/EP2002/008095 WO2003022267A1 (en) 2001-07-20 2002-07-19 Pharmaceutical compositions containing terbinafin and use thereof

Publications (1)

Publication Number Publication Date
MXPA04000627A true MXPA04000627A (es) 2004-04-20

Family

ID=27256227

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04000627A MXPA04000627A (es) 2001-07-20 2002-07-19 COMPOSICIONES FARMACeUTICAS Y USO DE LAS MISMAS.

Country Status (27)

Country Link
US (2) US20040198838A1 (enExample)
EP (1) EP1411921B2 (enExample)
JP (3) JP2005503399A (enExample)
KR (2) KR100699958B1 (enExample)
CN (1) CN100358518C (enExample)
AR (1) AR034813A1 (enExample)
AT (1) ATE381329T1 (enExample)
AU (1) AU2002321249B2 (enExample)
BR (1) BR0211198A (enExample)
CA (1) CA2453263C (enExample)
CY (1) CY1107861T1 (enExample)
DE (1) DE60224194T3 (enExample)
DK (1) DK1411921T4 (enExample)
ES (1) ES2295381T5 (enExample)
HU (1) HUP0401200A3 (enExample)
IL (2) IL159591A0 (enExample)
MX (1) MXPA04000627A (enExample)
MY (1) MY136136A (enExample)
NO (1) NO332268B1 (enExample)
NZ (1) NZ530648A (enExample)
PE (1) PE20030287A1 (enExample)
PL (1) PL365416A1 (enExample)
PT (1) PT1411921E (enExample)
RU (1) RU2298402C2 (enExample)
SI (1) SI1411921T2 (enExample)
TW (1) TWI302460B (enExample)
WO (1) WO2003022267A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR034813A1 (es) † 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
AU2003244633A1 (en) * 2002-07-02 2004-01-23 Novartis Ag Methods for the treatment of sinusitis
JP2005060310A (ja) * 2003-08-13 2005-03-10 Towa Yakuhin Kk 不快な味をマスキングする経口投与用製剤
JP2005187339A (ja) * 2003-12-24 2005-07-14 Iwaki Seiyaku Co Ltd 耐光性塩酸テルビナフィンフィルムコート錠
JP4999297B2 (ja) * 2005-08-10 2012-08-15 高田製薬株式会社 高含量塩酸テルビナフィン小型錠剤
WO2007110753A2 (en) * 2006-03-28 2007-10-04 Wockhardt Ltd Extended release dosage forms of metoprolol
CN1820744B (zh) * 2006-04-04 2011-01-26 中国人民解放军军事医学科学院毒物药物研究所 磷酸奥司他韦颗粒剂及其制备方法
CA2648495C (en) * 2006-04-26 2016-07-05 Alphapharm Pty Ltd Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
EP2029113A2 (en) * 2006-06-07 2009-03-04 Novartis AG Process for making multiparticulates using a roller compactor
MX2011007779A (es) * 2009-01-28 2011-08-12 Novartis Ag Formulaciones galenicas de compuestos organicos.
WO2010086732A1 (en) * 2009-01-30 2010-08-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Stable compositions for nail and skin treatment
CN102198111A (zh) * 2011-06-17 2011-09-28 哈尔滨乐泰药业有限公司 一种抗真菌药物片剂的制备方法
WO2013043143A1 (ru) * 2011-09-21 2013-03-28 Slyusar Viktor Timopheevich Способ снижения лишнего веса
US10071058B2 (en) * 2012-03-07 2018-09-11 Santarus, Inc. Controlled-release solid dosage forms of mesalamine
IL296490B1 (en) * 2016-03-15 2025-09-01 Acer Therapeutics Inc Tasty compositions containing sodium phenylbutyrate and their uses
WO2018069388A1 (en) 2016-10-11 2018-04-19 Khalifa University of Science and Technology Coated chloride salt particles and methods of making and using the same
FR3069545B1 (fr) * 2017-07-27 2020-10-16 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Composition d'enrobage exempte de dioxyde de titane
CN109833301A (zh) * 2017-11-29 2019-06-04 天津市保灵动物保健品有限公司 一种犬猫用盐酸特比萘芬风味片及其制备工艺
CN109925296B (zh) * 2017-12-19 2021-09-07 四川济生堂药业有限公司 一种中药微丸的包衣方法
CN112156078A (zh) * 2020-11-11 2021-01-01 乐泰药业有限公司 一种盐酸特比萘芬片、其制备方法以及杂质与质量检测方法
US20220175812A1 (en) 2020-12-03 2022-06-09 Battelle Memorial Institute Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery
JP2024516108A (ja) 2021-04-07 2024-04-12 バテル・メモリアル・インスティテュート 非ウイルス性担体を同定および使用するための迅速な設計、構築、試験、および学習技術
CN115869273B (zh) * 2022-10-31 2025-09-30 修正药业集团长春高新制药有限公司 一种盐酸特比萘芬片及其制备方法
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
US12441996B2 (en) 2023-12-08 2025-10-14 Battelle Memorial Institute Use of DNA origami nanostructures for molecular information based data storage systems

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK62184D0 (da) † 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
DE3572440D1 (en) * 1984-06-19 1989-09-28 Basf Ag Gastro-resistant cylindrical pancreatine-microtablets
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
US4894375A (en) * 1986-09-29 1990-01-16 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
RU2033991C1 (ru) * 1989-06-08 1995-04-30 Ф.Хоффманн-Ля Рош Аг Производные аминоалкилбензола или их фармацевтически приемлемые соли с кислотами
DE3937455A1 (de) * 1989-11-10 1991-05-16 Nordmark Arzneimittel Gmbh Antacidatabletten
GB9111477D0 (en) * 1991-05-29 1991-07-17 Sandoz Ltd Pharmaceutical composition
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
US5415872A (en) * 1992-06-22 1995-05-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
US5234697A (en) * 1992-06-22 1993-08-10 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
US5578304A (en) * 1992-06-22 1996-11-26 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5332727A (en) * 1993-04-29 1994-07-26 Birkmayer U.S.A. Stable, ingestable and absorbable NADH and NADPH therapeutic compositions
WO1995016465A1 (en) * 1993-12-14 1995-06-22 Sandoz Ltd. Pharmaceutical compositions containing alkyl polyoxyalkylene carboxylates
GB2290965A (en) * 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
FR2722102B1 (fr) * 1994-07-11 1996-08-23 Cird Galderma Utilisation de particules creuses deformables dans une composition cosmetique et/ou dermatologique, contenant des matieres grasses
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
FR2751878B1 (fr) * 1996-07-30 1998-09-04 Oreal Utilisation dans une composition d'un extrait d'au moins une labiee
US5814230A (en) * 1996-08-30 1998-09-29 Willis; H. Craig Apparatus and method for separation of solids from liquid
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
FR2755011B1 (fr) * 1996-10-31 1998-11-20 Cird Galderma Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles et/ou les dommages aigus induits par les rayonnements u.v.
CN1244119A (zh) * 1997-01-06 2000-02-09 辉瑞大药厂 迅速释放和掩蔽味觉的药物剂型
US6342250B1 (en) * 1997-09-25 2002-01-29 Gel-Del Technologies, Inc. Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices
FR2771291B1 (fr) † 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
DE19842753A1 (de) † 1998-09-18 2000-03-23 Bayer Ag Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
US8293277B2 (en) * 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US20010055613A1 (en) * 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
EP2260836B1 (en) * 1998-11-25 2016-08-10 Cima Labs Inc. Rapid release tablet with coated drug-containing core and surrounding taste masking layer
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
NZ513037A (en) † 1999-01-29 2003-05-30 Disphar Internat B Coated sustained release pharmaceutical composition for the release of an agent in the gastrointestinal tract
US6248363B1 (en) † 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
CN1116033C (zh) * 1999-07-08 2003-07-30 齐鲁制药厂 一种治疗阴道炎的泡腾片剂及其制法
JP2003506480A (ja) * 1999-08-17 2003-02-18 ノバルテイス・コンシユーマー・ヘルス・エス・アー 急速に溶解する剤形およびその製造方法
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
WO2001062229A1 (en) † 2000-02-24 2001-08-30 Advanced Pharma, Inc. Therapeutic product, use and formulation thereof
DE10017996A1 (de) * 2000-04-11 2001-10-18 Pierre Foss Lamisil-Intervall-System
GB0014448D0 (en) * 2000-06-13 2000-08-09 Novartis Ag Organic compounds
AR034813A1 (es) † 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
WO2004069157A2 (en) * 2003-01-17 2004-08-19 Ophthalmic Research Associates, Inc. Combinational use of long-acting and short-acting anti-histamines for ocular allergies

Also Published As

Publication number Publication date
DE60224194T2 (de) 2008-12-24
AU2002321249B2 (en) 2005-10-27
KR20060076331A (ko) 2006-07-04
WO2003022267A1 (en) 2003-03-20
EP1411921B1 (en) 2007-12-19
KR100651110B1 (ko) 2006-12-21
KR100699958B1 (ko) 2007-03-28
IL159591A0 (en) 2004-06-01
ATE381329T1 (de) 2008-01-15
EP1411921B2 (en) 2010-08-18
SI1411921T2 (sl) 2010-12-31
AR034813A1 (es) 2004-03-17
PT1411921E (pt) 2008-03-12
IL159591A (en) 2012-06-28
NZ530648A (en) 2007-04-27
JP2005503399A (ja) 2005-02-03
EP1411921A1 (en) 2004-04-28
KR20040028935A (ko) 2004-04-03
JP2012136523A (ja) 2012-07-19
HUP0401200A2 (hu) 2004-10-28
DE60224194D1 (de) 2008-01-31
DE60224194T3 (de) 2011-03-17
RU2004105263A (ru) 2005-04-20
DK1411921T4 (da) 2010-11-08
CN1527706A (zh) 2004-09-08
CA2453263C (en) 2010-12-07
HUP0401200A3 (en) 2008-03-28
TWI302460B (en) 2008-11-01
DK1411921T3 (da) 2008-04-21
SI1411921T1 (sl) 2008-06-30
PL365416A1 (en) 2005-01-10
BR0211198A (pt) 2004-08-10
NO332268B1 (no) 2012-08-13
NO20040254L (no) 2004-03-22
PE20030287A1 (es) 2003-05-06
CA2453263A1 (en) 2003-03-20
RU2298402C2 (ru) 2007-05-10
ES2295381T5 (es) 2011-01-31
HK1067299A1 (en) 2005-04-08
MY136136A (en) 2008-08-29
JP2008280351A (ja) 2008-11-20
US20080286356A1 (en) 2008-11-20
US20040198838A1 (en) 2004-10-07
ES2295381T3 (es) 2008-04-16
CN100358518C (zh) 2008-01-02
CY1107861T1 (el) 2013-06-19

Similar Documents

Publication Publication Date Title
MY136136A (en) Pharmaceutical compositions containing terbinafin and use thereof
CA2494234A1 (en) Methods and dosage forms for controlled delivery of paliperidone
MY125766A (en) Flash-melt oral dosage formulation
PT797991E (pt) Formulacao com libertacao prolongada contendo venlafaxina
DE60310039D1 (de) Pharmazeutische tablette
TW200500098A (en) Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
WO2004112756A8 (en) Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
BR0015188A (pt) Composições farmacêuticas
EP2269613A3 (en) Solid orald dosage form comprising a combination of metformin and glibenclamide
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
SG157406A1 (en) Oral medicament for the modified release of at least one active principle, in multi-microcapsule form
GEP20063882B (en) Dosage regimen and pharmaceutical composition for emergency contraception
ZA200301007B (en) Process for preparing pharmaceutical compositions for use with soft gelatin formulations.
MY127350A (en) Flash-melt oral dose formulations
MX2007015480A (es) Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
HUP0004966A3 (en) Pharmaceutical composition for oral administration in the form of matrix tablet enabling the prolonged release of trimetazidine
WO2001041742A3 (en) Antiviral medication
NZ504460A (en) Sustained release formulations containing venlafaxine
WO2002024203A3 (en) Controlled release formulations for oral administration
PL373456A1 (en) Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
DE60111503D1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
IL179177A (en) A pharmaceutical product including acyclovir and delivery compound, dosage unit, use of acyclovir in the preparation of the pharmaceutical product, use of the pharmaceutical product in the preparation of a drug and a method for the preparation of the pharmaceutical product
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
CA2473718A1 (en) Immediate-release pharmaceutical dosage form comprising polymorphous tibolone

Legal Events

Date Code Title Description
FG Grant or registration